Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
56.21
+1.26 (2.29%)
At close: May 29, 2026, 4:00 PM EDT
56.90
+0.69 (1.23%)
After-hours: May 29, 2026, 7:59 PM EDT
Hinge Health Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Hinge Health stock has a consensus rating of "Buy" and an average price target of $70.73. The average 1-year stock price forecast is 25.83% higher than the current stock price, while the lowest is $55 (-2.15%) and the highest is $95 (+69.01%).
Price Target: $70.73 (+25.83%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Hinge Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 9 | 9 | 9 | 8 | 8 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 17 | 17 | 17 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $72 | Buy | Reiterates | $72 | +28.09% | May 18, 2026 |
| William Blair | William Blair | Buy Reiterates $55 | Buy | Reiterates | $55 | -2.15% | May 8, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $65 → $80 | Buy | Maintains | $65 → $80 | +42.32% | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $59 → $67 | Buy | Reiterates | $59 → $67 | +19.20% | May 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $53 → $63 | Buy | Maintains | $53 → $63 | +12.08% | May 7, 2026 |
Financial Forecast
Revenue This Year
804.60M
from 587.86M
Increased by 36.87%
Revenue Next Year
967.91M
from 804.60M
Increased by 20.30%
EPS This Year
2.31
from -7.77
EPS Next Year
3.00
from 2.31
Increased by 30.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 845.8M | 1.1B | ||||
| Avg | 804.6M | 967.9M | ||||
| Low | 721.0M | 849.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 43.9% | 34.5% | ||||
| Avg | 36.9% | 20.3% | ||||
| Low | 22.7% | 5.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 2.93 | 3.74 | ||||
| Avg | 2.31 | 3.00 | ||||
| Low | 1.00 | 1.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | 61.9% | ||||
| Avg | - | 30.1% | ||||
| Low | - | -40.6% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.